Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Delivery

Background:

• Antisense oligonucleotides (ASOs) exhibit poor pharmacokinetic properties and cellular uptake.
• Polyethylene glycol (PEG) attachment can improve ASO solubility and tissue distribution.
• Long PEG chains may reduce ASO hybridization efficiency and pharmacodynamic effects.

Purpose of the Study:

• To investigate the impact of short PEG ligands on the in vitro efficacy of antisense agents.
• To evaluate the effect of PEGylation on ASO secondary structure and target binding affinity.
• To assess the gene silencing activity of PEGylated ASOs in a cellular tumor model.

Main Methods:

• Circular dichroism spectroscopy to analyze oligonucleotide secondary structure.
• Hybridization assays to determine binding affinity to complementary strands.
• Luciferase reporter assay in an in vitro tumor model to measure gene silencing.

Main Results:

• Tethering of PEG12-chains to phosphodiester and phosphorothioate ASOs did not affect secondary structure.
• PEGylation with short chains did not reduce the affinity of ASOs to their complementary strand.
• In vitro gene silencing activity remained unchanged, with a slight improvement observed for phosphorothioate conjugates.

Conclusions:

• Short PEG ligands can be effectively used to modify ASO properties without compromising their antisense activity.
• PEGylation with short chains offers a promising strategy to enhance ASO delivery and therapeutic potential.
• This approach maintains or slightly improves gene silencing efficacy, suggesting a viable therapeutic strategy.